The Nashville Hematology Conference brought together top national experts and community practitioners to explore the latest updates and challenges in the management of hematologic malignancies. The inaugural event took place at the Country Music Hall of Fame® and Museum in Nashville, TN, from Thursday, February 26, 2026, to Saturday, February 28, 2026, and was intentionally designed to create a fun, informative, and innovative experience that meaningfully engaged both academic and community clinicians.

This 2-day anticipated CE-accredited conference equipped attendees with the knowledge needed to navigate increasingly complex treatment landscapes across hematologic malignancies and to manage patients throughout therapy. Attendees examined current standards of care and evaluated how emerging data may influence treatment algorithms across a range of lymphoid and myeloid diseases.

The conference featured engaging lectures on evolving standards of care, management of relapse after initial therapy, the integration of T‑cell redirecting therapies into community practice, and strategies for treating later relapse. Hot topic discussions—spanning healthcare policy, MRD in hematologic malignancies, and ongoing controversies in treatment—were explored through a community‑focused lens.

Faculty experts examined and debated treatment options across hematologic malignancies while keeping the unique challenges faced by community practitioners at the forefront. Throughout the conference, attendees participated in live Q&A sessions and took advantage of numerous opportunities for networking and personal discussion. The Nashville Hematology Conference was designed to provide attendees with the practical tools needed to provide the most current, evidence-based care for patients with hematologic malignancies.